肺作为COVID-19的目标:机理性见解和可能的治疗候选分子
Sadiya Bi Shaikh1, Ashwini Prabhu1, Akarsha B1
1Yenepoya Research Centre, Yenepoya (Deemed to be University), Deralakatte, Mangalore 575 018, Karnataka, India.
Journal of infection and public health
|February 17, 2024
概括
这篇评论详细介绍了SARS-CoV-2如何影响肺部,导致严重的COVID-19和急性呼吸困扰综合征 (ARDS). 它探索潜在的药物标和新疗法的天然化合物.
科学领域:
- 病毒学 病毒学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 导致COVID-19,这是一个影响呼吸系统的全球流行病.
- 目前对危急COVID-19病例的治疗方法,特别是伴随疾病的治疗方法,有效性有限.
- 了解SARS-CoV-2的病原性对于开发有效的治疗策略至关重要.
研究的目的:
- 阐明SARS-CoV-2肺部热流的分子机制及其在严重COVID-19中的作用.
- 确定抗病毒疗法潜在的分子标.
- 评估天然抗炎化合物作为COVID-19的辅助治疗方法.
主要方法:
- 关于SARS-CoV-2感染分子机制的文献综述.
- 分析有关COVID-19病原和治疗的现有数据.
- 探索潜在的治疗点和天然化合物.
主要成果:
- SARS-CoV-2 向肺细胞,在严重情况下可能导致急性呼吸困扰综合征 (ARDS).
- 特定的病毒蛋白和宿主细胞相互作用是致病性的关键.
- 一些天然化合物表现出抗炎性质,可能有利于COVID-19患者.
结论:
- 更深入地了解SARS-CoV-2分子机制对于改善COVID-19治疗至关重要.
- 针对特定的病毒或宿主因素提供了可行的治疗途径.
- 天然抗炎药物显示出作为辅助疗法的前景,补充传统治疗方法.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
10:12Establishing Human Lung Organoids and Proximal Differentiation to Generate Mature Airway Organoids
Published on: March 23, 2022
8.2K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
